The DYNAMIC Hollow Fiber Dialyzer DH-Series are indicated for use whenever a patient is in acute or chronic renal failure and hemodialysis is prescribed by a physician. Therefore, use of this device should be only on the direction of a physician who has evaluated all of the aspects of the patient's illness.

Device Description

Blood enters a blood inlet port where it is distributed to hollow fibers. Each hollow fiber has an inner diameter of 200 microns and a wall thickness of 8 microns. The fibers used in this device which is substantially equivalent to the fibers utilized in the Focus R-Series Hollow Fiber Dialyzers (K914790) and Gambro GFS plus Series Hemodialyzer (K902481), which have been previously approved under a 510(k) Notification. The wall thickness of the hollow fibers in Focus R-Series Hollow Fiber Dialyzers and the proposed device is 8 microns. The inner diameter of hollow fibers in both Focus R-Series Hollow Fiber Dialyzers, Gambro GFS plus Series Hemodialyzer and the proposed device is 200 microns. The patient's blood traverses the inside of the hollow fibers and exits the device via a blood exit port.

AI/ML Overview

The provided text describes a 510(k) submission for a medical device, the DYNAMIC Hollow Fiber Dialyzer DH-Series. The primary purpose of a 510(k) is to demonstrate that the new device is "substantially equivalent" to a legally marketed predicate device. This typically involves showing that the device performs at least as well as the predicate device in relevant performance metrics.

Based on the provided text, here's a breakdown of the requested information:

1. Table of Acceptance Criteria and Reported Device Performance

The document does not explicitly state "acceptance criteria" as numerical thresholds that must be met. Instead, the approach is to demonstrate substantial equivalence to predicate devices. The "performance" is reported by stating that the device is substantially equivalent to these predicates.

Performance Metric	Acceptance Criteria (Implicit)	Reported Device Performance
Urea Clearance	Substantially equivalent to predicate devices	"proposed device is substantially equivalent to Focus R-Series Hollow Fiber Dialyzers 120H-R(K914790) , Gambro GFS plus 20 Hemodialyzer (K902481), and DYNAMIC Hollow Fiber Dialyzer DC-Series (K973291) for in vitro performance."
Creatinine Clearance	Substantially equivalent to predicate devices	Same as above.
Phosphate Clearance	Substantially equivalent to predicate devices	Same as above.
Vitamin B12 Clearance	Substantially equivalent to predicate devices	Same as above.
Ultrafiltration Coefficient	Substantially equivalent to predicate devices	Same as above.
Construction, Design, Intended Use, Function	Substantially equivalent to predicate devices	"substantially equivalent in construction, design, intended use, and function to other hemodialyzers currently marketed in the United States."
Materials	Similar to predicate devices	"similarities are noted in the design and materials employed to accomplish the same intended use."
Sterilization Method	Substantially equivalent to predicate devices	"sterilized by ethylene oxide gas," which is also used by predicate devices.

2. Sample Size Used for the Test Set and Data Provenance

The document states "In vitro testing was performed on the proposed device".

Sample Size: The document does not specify the sample size for the in vitro testing. It only mentions that testing was performed on "the proposed device."
Data Provenance: The data is from in vitro testing. The country of origin for the data is implied to be Taiwan, R.O.C., where the submitter (DYNAMIC TECHNOLOGY CORP.) is located. It is prospective data as it was generated to support this 510(k) submission for the new device.

3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts

This type of information is not applicable to this submission. The "ground truth" for hollow fiber dialyzers in this context refers to the measured performance characteristics (clearances, ultrafiltration) of the device itself and its comparison to predicate devices, not subjective expert assessment of images or clinical outcomes. The performance is measured directly in a lab setting.

4. Adjudication Method for the Test Set

This is not applicable. As stated above, the performance metrics are objective laboratory measurements, not subjective evaluations requiring adjudication.

5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study

This is not applicable. MRMC studies are typically used for diagnostic imaging devices where human readers interpret medical images. This document describes a hollow fiber dialyzer, which is a therapeutic device, not an imaging device.

6. Standalone (Algorithm Only) Performance Study

This is not applicable. This device is a physical medical device (dialyzer), not an algorithm or AI system. Therefore, standalone algorithm performance is not relevant.

7. Type of Ground Truth Used

The "ground truth" for the performance claims are the objective, measurable results of in vitro laboratory tests (urea, creatinine, phosphate, vitamin B12 clearances, and ultrafiltration coefficient). The comparison is then made against the established performance characteristics of the predicate devices.

8. Sample Size for the Training Set

This is not applicable. The device is a physical medical device, not a machine learning model, so there is no concept of a "training set" in this context.

9. How the Ground Truth for the Training Set Was Established

This is not applicable for the same reasons as point 8.

Summary

{0}------------------------------------------------

Image /page/0/Picture/0 description: The image shows a handwritten date, "4/19/99". The numbers are written in black ink on a white background. The handwriting is somewhat stylized, with the numbers being tall and thin.

K990159

510(K) SUMMARY

SUBMITTER: Yaw C. Yang, Ph.D. 2F, 53, Park Ave. II, Science-Based Industrial Park. Hsinchu, Taiwan, R.O.C. Tel.: 886-3-578-9566 Fax: 886-3-579-9541

Jan./11/1999 DATE PREPARED:

DEVICE NAME : DYNAMIC Hollow Fiber Dialyzer DH-Series Focus R-Series Hollow Fiber Dialyzers PREDICATE DEVICE : Gambro GFS plus Series Hemodialyzer Dynamic Hollow Fiber Dialyzer DC-series

Device Description

{1}------------------------------------------------

K990159

Page 2 of 3

Predicate Devices

The DYNAMIC Hollow Fiber Dialyzer DH-Series Dialyzers are substantially equivalent in construction, design, intended use, and function to other hemodialyzers currently marketed in the United States. The DYNAMIC Hollow Fiber Dialyzer DH-Series Dialyzers are substantially equivalent in function, design, and operation to the Focus R-Series Hollow Fiber Dialyzers , Gambro GFS plus Series Hemodialyzer, and DYNAMIC Hollow Fiber Dialyzer DC-Series(K973291), which have been previously approved for marketing in the United States under 510(K) Notifications.

Intended Use

The DYNAMIC Hollow Fiber Dialyzer DH-Series are indicated for use whenever a patient is in acute or chronic renal failure and hemodialysis is prescribed by a physician. Therefore, use of the device should be only on direction of a physician who has evaluated all of the aspects of the patient's illness. The indication statement is essentially the same as the indication statement of the predicate devices.

Technological Characteristics

Comparing the proposed device to the predicate devices, similarities are noted in the design and materials employed to accomplish the same intended use. All of the proposed device , Gambro GFS plus Series Hemodialyzer, and DYNAMIC Hollow Fiber Dialyzer DC-Series utilize polycarbonate for the header material and polyurethane for the membrane potting material. The proposed devices, Focus R-Series Hollow Fiber Dialyzers, and DYNAMIC Hollow Fiber Dialyzer DC-Series are sterilized by ethylene oxide gas.

In Vitro Performance

In vitro testing was performed on the proposed device to

{2}------------------------------------------------

K990159

determine the following: urea, creatinine, phosphate, and vitamin B12 clearances, and ultrafiltration coefficient. The result indicates that the proposed device is substantially equivalent to Focus R-Series Hollow Fiber Dialyzers 120H-R(K914790) , Gambro GFS plus 20 Hemodialyzer (K902481), and DYNAMIC Hollow Fiber Dialyzer DC-Series (K973291) for in vitro performance.

Conclusions

Testing performed on the DYNAMIC Hollow Fiber DH-Series indicated that it is safe, effective, and performs as well as the predicate devices, when used in accordance with the instructions for use.

{3}------------------------------------------------

Image /page/3/Picture/1 description: The image is a black and white seal for the Department of Health & Human Services - USA. The seal is circular with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is a stylized image of three curved lines that resemble a person.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

APR 1 9 1999

Yaw C. Yang, Ph.D. President & CEO DYNAMIC TECHNOLOGY CORP. 2F. No. 53. Park Ave. II Science-Based Industrial Park Hsinchu, TAIWAN, R.O.C.

Re: K990159 DYNAMIC Hollow Fiber Dialyzer DH-Series Dated: January 11, 1999 Received: January 19, 1999 Requiatory Class: II 21 CFR 876.5820/Procode: 78 FJI

Dear Dr. Yang:

We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Requilations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.

This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your labeling requlation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4613. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597, or at its internet address "http://www.fda.gov/cdrh/dsma/dsmamain.html".

Sincerely yours,

CAPT Daniel G. Schultz, M.D. Acting Director, Division of Reproductive, Abdominal, Ear, Nose and Throat, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{4}------------------------------------------------

510(k) Number (if known): K990159

Device Name: DYNAMIC Hollow Fiber Dialyzer DH-Series

Indications for Use:

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE NEEDED)

Concurrence of CDRH, Office Device Evaluation (ODE)

David L. Syam

(Division Sign-Off Division of Reproductive, Abdominal, ENT, and Radiological Devices 510(k) Number

Prescription Use
(Per 21 CFR 801.109)
OR

Over-The -Counter Use

Regulation Number and Section

§ 876.5820 Hemodialysis system and accessories.

(a)
Identification. A hemodialysis system and accessories is a device that is used as an artificial kidney system for the treatment of patients with renal failure or toxemic conditions and that consists of an extracorporeal blood system, a conventional dialyzer, a dialysate delivery system, and accessories. Blood from a patient flows through the tubing of the extracorporeal blood system and accessories to the blood compartment of the dialyzer, then returns through further tubing of the extracorporeal blood system to the patient. The dialyzer has two compartments that are separated by a semipermeable membrane. While the blood is in the blood compartment, undesirable substances in the blood pass through the semipermeable membrane into the dialysate in the dialysate compartment. The dialysate delivery system controls and monitors the dialysate circulating through the dialysate compartment of the dialyzer.(1) The extracorporeal blood system and accessories consists of tubing, pumps, pressure monitors, air foam or bubble detectors, and alarms to keep blood moving safely from the blood access device and accessories for hemodialysis (§ 876.5540) to the blood compartment of the dialyzer and back to the patient.
(2) The conventional dialyzer allows a transfer of water and solutes between the blood and the dialysate through the semipermeable membrane. The semipermeable membrane of the conventional dialyzer has a sufficiently low permeability to water that an ultrafiltration controller is not required to prevent excessive loss of water from the patient's blood. This conventional dialyzer does not include hemodialyzers with the disposable inserts (Kiil type) (§ 876.5830) or dialyzers of high permeability (§ 876.5860).
(3) The dialysate delivery system consists of mechanisms that monitor and control the temperature, conductivity, flow rate, and pressure of the dialysate and circulates dialysate through the dialysate compartment of the dialyzer. The dialysate delivery system includes the dialysate concentrate for hemodialysis (liquid or powder) and alarms to indicate abnormal dialysate conditions. This dialysate delivery system does not include the sorbent regenerated dialysate delivery system for hemodialysis (§ 876.5600), the dialysate delivery system of the peritoneal dialysis system and accessories (§ 876.5630), or the controlled dialysate delivery system of the high permeability hemodialysis system § 876.5860).
(4) Remote accessories to the hemodialysis system include the unpowered dialysis chair without a scale, the powered dialysis chair without a scale, the dialyzer holder set, dialysis tie gun and ties, and hemodialysis start/stop tray.
(b)
Classification. (1) Class II (performance standards) for hemodialysis systems and all accessories directly associated with the extracorporeal blood system and the dialysate delivery system.(2) Class I for other accessories of the hemodialysis system remote from the extracorporeal blood system and the dialysate delivery system, such as the unpowered dialysis chair, hemodialysis start/stop tray, dialyzer holder set, and dialysis tie gun and ties. The devices subject to this paragraph (b)(2) are exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 876.9.